Drug
Pazopanib
Pazopanib: highest development phase Phase 1, developed by GlaxoSmithKline. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pazopanib NCT00540943 | Phase 1 | Neoplasms, Colorectal |
| pazopanib hydrochloride NCT01413113 | Phase 1 | Recurrent Thyroid Cancer |
Latest
No recent events.
Follow Pazopanib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.